Endo-Porter used to deliver Morpholinos into human primary fibroblasts
Jon Moulton
Tuesday, 15 September 2009 17:45 UTC
RodrÃguez-Pascau L, Coll MJ, Vilageliu L, Grinberg D. Antisense oligonucleotide treatment for a pseudoexon-generating mutation in the NPC1 gene causing Niemann-Pick type C disease. Hum Mutat. 2009 Aug 30. [Epub ahead of print]
Updated 15 September 2009 17:46 UTC
-
Replies